×
About 8,700 results

ALLMedicine™ Esophagitis Center

Research & Reviews  2,402 results

Gastric Adenocarcinoma of the Fundic Gland Type: A Case Report.
https://doi.org/10.12659/AJCR.933474
The American Journal of Case Reports; Kakumoto A, Kuroda H et. al.

Dec 3rd, 2021 - BACKGROUND Gastric adenocarcinoma of the fundic gland type (GAFG) is an extremely rare neoplasm that consists of a mixed proliferation of oxyntic and chief cells. Differential diagnosis of GAFG is difficult in the absence of infiltration. Here, we...

Beyond the Eckardt Score: Patient-Reported Outcomes Measures in Esophageal Disorders.
https://doi.org/10.1007/s11894-021-00831-4 10.4137/HSI.S11093 10.1023/a:1015291021312 10.1111/joim.12409 10.1186/s13643-016-0307-4 10.1186/1745-6215-15-49 10.1136/bmj.f167 10.1016/0016-5085(92)91428-7 10.1001/jama.2019.8859 10.1038/ajg.2014.237 10.1111/j.1442-2050.2007.00670.x 10.1097/00004836-199203000-00004 10.1038/ajg.2016.20 10.1038/s41395-018-0256-8 10.2147/PPA.S142653 10.1038/ajg.2016.305 10.1038/ajg.2016.415 10.1007/s00455-009-9246-8 10.1016/j.jaci.2011.05.006 10.1111/apt.12413 10.1038/ajg.2012.443 10.1097/00000658-199711000-00009 10.1177/0194599811409857 10.1001/jama.2015.2996 10.1016/j.gie.2014.04.014 10.1136/gut.41.1.87 10.1136/gut.2003.029298 10.1136/gutjnl-2014-308649 10.1007/s11605-019-04465-w 10.1007/s00464-019-06952-2 10.1136/gut.50.6.765 10.1111/nmo.13287 10.1007/s00464-016-5352-5 10.1111/j.1442-2050.2009.01006.x 10.1111/j.1572-0241.2005.50141.x 10.1111/j.1442-2050.2008.00815.x 10.1056/NEJMra1502863 10.1016/j.cgh.2019.08.050 10.1111/apt.13370 10.1038/ajg.2015.32 10.1111/j.1365-2036.2011.04791.x 10.1007/s11136-004-0613-5 10.1007/s11894-008-0052-5 10.1093/gastro/gou061 10.1053/j.gastro.2017.07.045 10.2147/CEG.S121056 10.5056/jnm18085 10.1136/gutjnl-2017-314722 10.1097/01.mcg.0000225693.69745.49 10.1001/jama.295.13.1566 10.1111/j.1742-1241.2007.01586.x 10.3122/jabfm.18.5.393 10.1111/j.1572-0241.2001.03932.x 10.2165/00044011-200424040-00002 10.1186/1477-7525-1-62 10.1186/1477-7525-8-85 10.1111/j.1365-2036.2008.03683.x 10.1023/a:1010660425522 10.1159/000101077 10.1111/j.1572-0241.2005.40122.x 10.1097/MEG.0b013e328358bf74 10.1111/j.1572-0241.2001.03451.x 10.1111/dote.12163 10.1186/1471-230x-14-17 10.1186/1477-7525-6-31 10.1159/000100511 10.1111/j.1365-2036.2007.03271.x 10.1111/j.1365-2036.2009.04142.x 10.1080/003655298750026697 10.5056/jnm.2011.17.2.164 10.1177/009286159603000122 10.1046/j.1442-2050.2000.00129.x 10.1159/000016881 10.1007/bf02064375 10.1155/2003/530984 10.1159/000101078 10.1111/j.1365-2036.2008.03641.x 10.1097/MCG.0b013e31802e849f 10.1159/000101082 10.1186/s12913-018-2898-z 10.1093/jamia/ocv191 10.1007/s004550010013 10.1016/s0016-5085(00)70137-5 10.1016/j.ejca.2007.07.005 10.1016/s0959-8049(03)00270-3
Current Gastroenterology Reports; Dorsey YC, Song EJ et. al.

Dec 2nd, 2021 - To provide an overview of patient reported outcome measures (PROMs) and summarize their role in assessing undifferentiated dysphagia and common esophageal disorders, including achalasia, eosinophilic esophagitis (EoE), and gastroesophageal reflux ...

Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esop...
https://doi.org/10.1038/s41467-021-26939-9 10.1038/nature13127
Nature Communications; Shoda T, Kaufman KM et. al.

Nov 25th, 2021 - Eosinophilic esophagitis (EoE) is a chronic allergic inflammatory disease with a complex underlying genetic etiology. Herein, we conduct whole-exome sequencing of a multigeneration EoE pedigree (discovery set) and 61 additional multiplex families ...

PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer
https://clinicaltrials.gov/ct2/show/NCT02073968

Nov 24th, 2021 - PRIMARY OBJECTIVES: I. To estimate the efficacy (based on post-treatment PET findings) of dose-painted intensity-modulated radiotherapy (IMRT) with concurrent chemotherapy for locally-advanced non-small cell lung cancer (LA-NSCLC). SECONDARY OBJEC...

A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis
https://clinicaltrials.gov/ct2/show/NCT04682639

Nov 23rd, 2021 - The purpose of this study is to determine whether oral etrasimod is a safe and effective treatment for active eosinophilic esophagitis (EoE) in adult participants.

see more →

Guidelines  11 results

ACR Appropriateness Criteria® Epigastric Pain.
https://doi.org/10.1016/j.jacr.2021.08.006
Journal of the American College of Radiology : JACR; , Vij A et. al.

Nov 20th, 2021 - Epigastric pain can have multiple etiologies including myocardial infarction, pancreatitis, acute aortic syndromes, gastroesophageal reflux disease, esophagitis, peptic ulcer disease, gastritis, duodenal ulcer disease, gastric cancer, and hiatal h...

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Pr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868475
Clinical Pharmacology and Therapeutics; Lima JJ, Thomas CD et. al.

Aug 10th, 2020 - Proton pump inhibitors (PPIs) are widely used for acid suppression in the treatment and prevention of many conditions, including gastroesophageal reflux disease, gastric and duodenal ulcers, erosive esophagitis, Helicobacter pylori infection, and ...

Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA I...
https://doi.org/10.1053/j.gastro.2020.02.039
Gastroenterology Rank MA, Sharaf RN et. al.

May 4th, 2020 - Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus. Many new studies have been reported recently that describe EoE management. An expert panel was convened by the American Gastroenterological Association Institute ...

AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinic...
https://doi.org/10.1053/j.gastro.2020.02.038
Gastroenterology Hirano I, Chan ES et. al.

May 4th, 2020 - AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis.|2020|Hirano I,Chan ES,Rank MA,Sharaf RN,Stollman NH,|standards,organization & administration,stand...

AGA institute and the joint task force on allergy-immunology practice parameters clinic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135034
Annals of Allergy, Asthma & Immunology : Official Publica... Hirano I, Chan ES et. al.

Apr 28th, 2020 - AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis.|2020|Hirano I,Chan ES,Rank MA,Sharaf RN,Stollman NH,|therapeutic use,diagnosis,drug therapy,therap...

see more →

Drugs  592 results see all →

Clinicaltrials.gov  146 results

PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer
https://clinicaltrials.gov/ct2/show/NCT02073968

Nov 24th, 2021 - PRIMARY OBJECTIVES: I. To estimate the efficacy (based on post-treatment PET findings) of dose-painted intensity-modulated radiotherapy (IMRT) with concurrent chemotherapy for locally-advanced non-small cell lung cancer (LA-NSCLC). SECONDARY OBJEC...

A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis
https://clinicaltrials.gov/ct2/show/NCT04682639

Nov 23rd, 2021 - The purpose of this study is to determine whether oral etrasimod is a safe and effective treatment for active eosinophilic esophagitis (EoE) in adult participants.

MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC)
https://clinicaltrials.gov/ct2/show/NCT00618917

Nov 12th, 2021 - This is a Phase I-II study evaluating the feasibility, safety, and efficacy of swallowed MnSOD plasmid/liposome (PL) transgene given as protection against radiation-induced esophagitis during concurrent paclitaxel and carboplatin chemotherapy with...

A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Tre...
https://clinicaltrials.gov/ct2/show/NCT05055128

Nov 10th, 2021 - This is a randomized, double-blind, active comparator-controlled study with a parallel-group design including four arms with X842 and one arm with Lansoprazole. Randomization to one of the treatments with X842 twice daily (BID) 25 mg, 50 mg, 75 mg...

A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients
https://clinicaltrials.gov/ct2/show/NCT00000768

Nov 4th, 2021 - Long-term ganciclovir maintenance therapy has been recommended for CMV colitis or esophagitis following induction treatment. Oral ganciclovir is a likely candidate for maintenance because of its possible therapeutic value and ease of administratio...

see more →

News  311 results

Tidutamab Shows Early Tolerability, Active Immune Profile in Advanced Neuroendocrine Tumors
https://www.onclive.com/view/tidutamab-shows-early-tolerability-active-immune-profile-in-advanced-neuroendocrine-tumors

Nov 15th, 2021 - Tidutamab (previously XmAb18087) was found to be well tolerated with a best overall response of stable disease in patients with advanced, well-differentiated neuroendocrine tumors (NETs) of pancreatic, gastrointestinal (GI), lung and undetermined ...

JAK Inhibitors Offer Hope for Hard-to-Treat Atopic Dermatitis but Carry Black-Box Warnings
https://www.medscape.com/viewarticle/962464

Nov 7th, 2021 - Just a few years after the successful launch of dupilumab (Dupixent), new biologics are expanding the treatment arsenal for serious cases of atopic dermatitis. Yet as these topical and oral JAK inhibitors pave the way to more personalized care, sa...

Vonoprazan Beats PPIs in H pylori Eradication
https://www.medscape.com/viewarticle/962112

Nov 2nd, 2021 - In the treatment of Helicobacter pylori infection, combination therapies using the oral potassium-competitive acid blocker vonoprazan were superior to standard proton pump inhibitor (PPI)–based triple therapy, producing higher eradication rates, a...

Expert Explains Work Needed for Immunotherapy/RT Approaches in NSCLC
https://www.onclive.com/view/expert-explains-work-needed-for-immunotherapyrt-approaches-in-nsclc

Oct 6th, 2021 - James Larner, MD In non—small cell lung cancer (NSCLC), determining whether radiation can truly potentiate response to immunotherapy requires a better understanding of underlying permutations and pathways, explained James Larner, MD. Following f...

Sleeve Gastrectomy Has Higher GERD Risk Than Gastric Bypass
https://www.medscape.com/viewarticle/958583

Sep 13th, 2021 - (Reuters Health) - People with obesity who undergo bariatric surgery have a higher risk of gastroesophageal reflux disease (GERD) with sleeve gastrectomy than with Roux-en-Y gastric bypass, a randomized controlled trial found. Researchers randomiz...

see more →

Patient Education  18 results see all →